Center for Fertility and Reproductive Medicine, Division of Reproductive Endocrinology and Infertility, Department of Ob/Gyn, Cedars-Sinai Medical Center, 8635 West Third St., Los Angeles, CA 90048, USA.
Am J Physiol Endocrinol Metab. 2010 Jul;299(1):E101-9. doi: 10.1152/ajpendo.00534.2009. Epub 2010 Apr 20.
Forkhead L2 (FOXL2) is expressed in the ovary and acts as a transcriptional repressor of the steroidogenic acute regulatory (StAR) gene, a marker of granulosa cell differentiation. Human FOXL2 mutations that produce truncated proteins lacking the COOH terminus result in blepharophimosis/ptosis/epicanthus inversus (BPES) syndrome type I, which is associated with premature ovarian failure (POF). In this study, we investigated whether FOXL2's activity as a transcriptional repressor is regulated by phosphorylation. We found that FOXL2 is phosphorylated at a serine residue and, using yeast two-hybrid screening, identified LATS1 as a potential FOXL2-interacting protein. LATS1 is a serine/threonine kinase whose deletion in mice results in an ovarian phenotype similar to POF. Using coimmunoprecipitation and kinase assays, we confirmed that LATS1 binds to FOXL2 and demonstrated that LATS1 phosphorylates FOXL2 at a serine residue. Moreover, we found that FOXL2 and LATS1 are coexpressed in developing mouse gonads and in granulosa cells of small and medium follicles in the mouse ovary. Last, we demonstrated that coexpression with LATS1 enhances FOXL2's activity as a repressor of the StAR promoter, and this results from the kinase activity of LATS1. These results provide novel evidence that FOXL2 is phosphorylated by LATS1 and that this phosphorylation enhances the transcriptional repression of the StAR gene, a marker of granulosa cell differentiation. These data support our hypothesis that phosphorylation of FOXL2 may be a control mechanism regulating the rate of granulosa cell differentiation and hence, follicle maturation, and its dysregulation may contribute to accelerated follicular development and POF in BPES type I.
叉头框蛋白 L2(FOXL2)在卵巢中表达,作为类固醇急性调节(StAR)基因的转录抑制剂,StAR 基因是颗粒细胞分化的标志物。产生缺乏羧基末端的截断蛋白的人类 FOXL2 突变导致内眦赘皮/上睑下垂/内眦赘皮反转(BPES)综合征 I 型,与卵巢早衰(POF)相关。在这项研究中,我们研究了 FOXL2 作为转录抑制剂的活性是否受磷酸化调节。我们发现 FOXL2 在丝氨酸残基处被磷酸化,并通过酵母双杂交筛选鉴定 LATS1 为潜在的 FOXL2 相互作用蛋白。LATS1 是一种丝氨酸/苏氨酸激酶,其在小鼠中的缺失导致与 POF 相似的卵巢表型。通过共免疫沉淀和激酶测定,我们证实 LATS1 与 FOXL2 结合,并证明 LATS1 在丝氨酸残基处磷酸化 FOXL2。此外,我们发现 FOXL2 和 LATS1 在发育中的小鼠性腺和小鼠卵巢中小和中卵泡的颗粒细胞中共同表达。最后,我们证明与 LATS1 共表达增强了 FOXL2 作为 StAR 启动子抑制剂的活性,这是由于 LATS1 的激酶活性所致。这些结果提供了新的证据,表明 FOXL2 被 LATS1 磷酸化,并且这种磷酸化增强了 StAR 基因的转录抑制,StAR 基因是颗粒细胞分化的标志物。这些数据支持我们的假设,即 FOXL2 的磷酸化可能是调节颗粒细胞分化速度的控制机制,因此,卵泡成熟,其失调可能导致 BPES 型 I 中卵泡发育加速和 POF。